Spectrum Pharmaceuticals SPPI - FDA Decision Date - July 2, 2009

Spectrum Pharmaceuticals ( SPPI ) is expected to be receiving an FDA approval decision sometime next week....keep an eye on this stock.

Drug/indication: Zevalin for non-Hodgkin's lymphoma

FDA decision date: July 2

Spectrum is seeking FDA approval to expand the label for Zevalin to include consolidation therapy for patients with NHL. Zevalin is an effective drug that has been a commercial disappointment, so the company hopes the expanded FDA label will boost sales.

http://www.thestreet.com/story/10508908/2/biotech-calendar-key-fda-...